Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
ClinicalTrials.gov study NCT02856178. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)
ClinicalTrials.gov study NCT07131085. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT02662920. IPD Sharing: Not stated. Countries: 0. Publications: 0.
VA as Maintenance Therapy Post Allo-HSCT in MDS and AML
ClinicalTrials.gov study NCT06598384. IPD Sharing: NO. Countries: 0. Publications: 0.
Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML
ClinicalTrials.gov study NCT07338357. IPD Sharing: NO. Countries: 0. Publications: 0.
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML
ClinicalTrials.gov study NCT03138395. IPD Sharing: NO. Countries: 0. Publications: 0.
Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS
ClinicalTrials.gov study NCT06050941. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML
ClinicalTrials.gov study NCT00502385. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation
ClinicalTrials.gov study NCT06441084. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS
ClinicalTrials.gov study NCT05823480. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes
ClinicalTrials.gov study NCT00038870. IPD Sharing: Not stated. Countries: 0. Publications: 0.
CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05854966. IPD Sharing: NO. Countries: 0. Publications: 0.
Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML
ClinicalTrials.gov study NCT06133556. IPD Sharing: NO. Countries: 0. Publications: 0.
Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia
ClinicalTrials.gov study NCT04128020. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review
ClinicalTrials.gov study NCT06362031. IPD Sharing: NO. Countries: 0. Publications: 0.
Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission
ClinicalTrials.gov study NCT03070093. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study
ClinicalTrials.gov study NCT07264010. IPD Sharing: NO. Countries: 0. Publications: 0.
Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
ClinicalTrials.gov study NCT06295029. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE)
ClinicalTrials.gov study NCT05876832. IPD Sharing: NO. Countries: 0. Publications: 0.
Diagnosis and Treatment of Periodontal Disease in Patients With AML
ClinicalTrials.gov study NCT04530695. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.